These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34999268)

  • 21. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.
    Ray LA; Bujarski S; Courtney KE; Moallem NR; Lunny K; Roche D; Leventhal AM; Shoptaw S; Heinzerling K; London ED; Miotto K
    Neuropsychopharmacology; 2015 Sep; 40(10):2347-56. PubMed ID: 25801501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder.
    Heinzerling KG; Briones M; Thames AD; Hinkin CH; Zhu T; Wu YN; Shoptaw SJ
    J Neuroimmune Pharmacol; 2020 Jun; 15(2):238-248. PubMed ID: 31820289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of methamphetamine abuse treatment: Predictors of treatment completion and comparison of two residential treatment programs.
    Kamp F; Proebstl L; Hager L; Schreiber A; Riebschläger M; Neumann S; Straif M; Schacht-Jablonowsky M; Manz K; Soyka M; Koller G
    Drug Alcohol Depend; 2019 Aug; 201():8-15. PubMed ID: 31154239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P300 event-related potential in abstinent methamphetamine-dependent patients.
    Haifeng J; Wenxu Z; Hong C; Chuanwei L; Jiang D; Haiming S; Zhikang C; Din X; Jijun W; Min Z
    Physiol Behav; 2015 Oct; 149():142-8. PubMed ID: 26051625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moment-by-Moment in Women's Recovery (MMWR): Mindfulness-based intervention effects on residential substance use disorder treatment retention in a randomized controlled trial.
    Black DS; Amaro H
    Behav Res Ther; 2019 Sep; 120():103437. PubMed ID: 31419610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The transcranial direct current stimulation over prefrontal cortex combined with the cognitive training reduced the cue-induced craving in female individuals with methamphetamine use disorder: A randomized controlled trial.
    Xu X; Ding X; Chen L; Chen T; Su H; Li X; Ye Y; Shi W; Ji J; Zhao M; Zhong N; Jiang H
    J Psychiatr Res; 2021 Feb; 134():102-110. PubMed ID: 33383492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Four-week Tai Chi intervention decreases attention bias to drug cues in individuals with methamphetamine use disorder.
    He M; Yang S; Miao Y; Zhang W; Zhu D; Xu D
    Am J Drug Alcohol Abuse; 2021 Sep; 47(5):638-648. PubMed ID: 34325579
    [No Abstract]   [Full Text] [Related]  

  • 28. LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence.
    Ezard N; Dunlop A; Hall M; Ali R; McKetin R; Bruno R; Phung N; Carr A; White J; Clifford B; Liu Z; Shanahan M; Dolan K; Baker AL; Lintzeris N
    BMJ Open; 2018 Jul; 8(7):e020723. PubMed ID: 30030312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial.
    Rezaei F; Emami M; Zahed S; Morabbi MJ; Farahzadi M; Akhondzadeh S
    Daru; 2015 Jan; 23(1):2. PubMed ID: 25588930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex Differences in the Association Between Internalizing Symptoms and Craving in Methamphetamine Users.
    Hartwell EE; Moallem NR; Courtney KE; Glasner-Edwards S; Ray LA
    J Addict Med; 2016; 10(6):395-401. PubMed ID: 27504928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial.
    Anderson AL; Li SH; Markova D; Holmes TH; Chiang N; Kahn R; Campbell J; Dickerson DL; Galloway GP; Haning W; Roache JD; Stock C; Elkashef AM
    Drug Alcohol Depend; 2015 May; 150():170-4. PubMed ID: 25818061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction.
    Galloway GP; Buscemi R; Coyle JR; Flower K; Siegrist JD; Fiske LA; Baggott MJ; Li L; Polcin D; Chen CY; Mendelson J
    Clin Pharmacol Ther; 2011 Feb; 89(2):276-82. PubMed ID: 21178989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Add-on Buprenorphine to Matrix Program in Reduction of Craving and Relapse Among People With Methamphetamine Use Disorder: A Randomized Controlled Trial.
    Kheirabadi GR; Bahrami M; Shariat A; Tarrahi M
    J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):45-48. PubMed ID: 33347022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adding extended-release methylphenidate to psychological intervention for treatment of methamphetamine dependence: A double-blind randomized controlled trial.
    Noroozi A; Motevalian SA; Zarrindast MR; Alaghband-Rad J; Akhondzadeh S
    Med J Islam Repub Iran; 2020; 34():137. PubMed ID: 33437733
    [No Abstract]   [Full Text] [Related]  

  • 35. Withdrawal symptoms in abstinent methamphetamine-dependent subjects.
    Zorick T; Nestor L; Miotto K; Sugar C; Hellemann G; Scanlon G; Rawson R; London ED
    Addiction; 2010 Oct; 105(10):1809-18. PubMed ID: 20840201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Personalized Approach Bias Modification Smartphone App ("SWiPE") to Reduce Alcohol Use: Open-Label Feasibility, Acceptability, and Preliminary Effectiveness Study.
    Manning V; Piercy H; Garfield JBB; Clark SG; Andrabi MN; Lubman DI
    JMIR Mhealth Uhealth; 2021 Dec; 9(12):e31353. PubMed ID: 34890355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trace amine-associated receptor gene polymorphism increases drug craving in individuals with methamphetamine dependence.
    Loftis JM; Lasarev M; Shi X; Lapidus J; Janowsky A; Hoffman WF; Huckans M
    PLoS One; 2019; 14(10):e0220270. PubMed ID: 31600226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
    McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
    Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder.
    Roche DJO; Worley MJ; Courtney KE; Bujarski S; London ED; Shoptaw S; Ray LA
    Psychopharmacology (Berl); 2017 Jul; 234(13):1997-2007. PubMed ID: 28357460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Theta-Burst Stimulation Combined With Virtual-Reality Reconsolidation Intervention for Methamphetamine Use Disorder: Study Protocol for a Randomized-Controlled Trial.
    Wen Y; Hao X; Chen X; Qiao S; Li Q; Winkler MH; Wang F; Yan X; Wang F; Wang L; Jiang F; Pauli P; Dong X; Li Y
    Front Psychiatry; 2022; 13():903242. PubMed ID: 35865301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.